Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs
AM Mulhall, CA Droege, NE Ernst… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Phosphodiesterase (PDE) inhibitors modulate lung inflammation and cause
bronchodilation by increasing intracellular cyclic adenosine 3', 5'-monophosphate in airway …
bronchodilation by increasing intracellular cyclic adenosine 3', 5'-monophosphate in airway …
Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.
AM Mulhall, CA Droege, NE Ernst… - Expert Opinion on …, 2015 - europepmc.org
Phosphodiesterase (PDE) inhibitors modulate lung inflammation and cause bronchodilation
by increasing intracellular cyclic adenosine 3', 5'-monophosphate in airway smooth muscle …
by increasing intracellular cyclic adenosine 3', 5'-monophosphate in airway smooth muscle …
Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs
AM Mulhall, CA Droege, NE Ernst… - Expert opinion on …, 2015 - pubmed.ncbi.nlm.nih.gov
Introduction Phosphodiesterase (PDE) inhibitors modulate lung inflammation and cause
bronchodilation by increasing intracellular cyclic adenosine 3', 5'-monophosphate in airway …
bronchodilation by increasing intracellular cyclic adenosine 3', 5'-monophosphate in airway …